Caryn G. McDowell
2018
In 2018, Caryn G. McDowell earned a total compensation of $2.7M as Senior Vice President, General Counsel and Corporate Secretary at Revance Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $132,660 |
|---|---|
| Option Awards | $1,813,295 |
| Salary | $266,667 |
| Stock Awards | $452,800 |
| Other | $4,807 |
| Total | $2,670,229 |
McDowell received $1.8M in option awards, accounting for 68% of the total pay in 2018.
McDowell also received $132.7K in non-equity incentive plan, $266.7K in salary, $452.8K in stock awards and $4.8K in other compensation.
Rankings
In 2018, Caryn G. McDowell's compensation ranked 4,379th out of 14,244 executives tracked by ExecPay. In other words, McDowell earned more than 69.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,379 out of 14,244 | 69th |
Division Manufacturing | 1,630 out of 5,765 | 72nd |
Major group Chemicals And Allied Products | 586 out of 2,128 | 73rd |
Industry group Drugs | 490 out of 1,817 | 73rd |
Industry Pharmaceutical Preparations | 382 out of 1,391 | 73rd |
Source: SEC filing on March 25, 2019.
McDowell's colleagues
We found six more compensation records of executives who worked with Caryn G. McDowell at Revance Therapeutics in 2018.
2018
L Browne
Revance Therapeutics
Chief Executive Officer
2018
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2018
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
2018
Todd Zavodnick
Revance Therapeutics
Former Chief Commercial Officer and President, Aesthetics & Therapeutics
2018
Lauren Silvernail
Revance Therapeutics
Chief Financial Officer
2018
Cyril Allouche
Revance Therapeutics